Tag: clinical operations

Investigator Responsibilities When Care Is Delivered Remotely

November 16, 2025November 15, 2025 digi

Investigator Responsibilities When Care Is Delivered Remotely Investigator Responsibilities When Care Is Delivered Remotely The shift towards remote care in clinical trials has fundamentally transformed the way that healthcare is delivered to trial participants. As clinical operations, regulatory affairs, and medical affairs professionals in the US, UK, and EU navigate this landscape, it’s essential to…

GCP in Digital/Decentralized Settings

Issue Escalation Pathways From Site to CRO to Sponsor

November 16, 2025November 15, 2025 digi

Issue Escalation Pathways From Site to CRO to Sponsor Issue Escalation Pathways From Site to CRO to Sponsor In today’s intricate landscape of clinical trials, particularly in the context of covid clinical trials, ensuring effective communication pathways for issue escalation is imperative. This tutorial serves as a comprehensive guide for clinical operations, regulatory affairs, and…

Site Communications & Issue Escalation

Documenting Communications in CTMS, eTMF and Site Files

November 16, 2025November 15, 2025 digi

Documenting Communications in CTMS, eTMF and Site Files Documenting Communications in CTMS, eTMF and Site Files Effective communication during clinical trials is critical to ensuring compliance and facilitating efficient operations. This guide outlines the steps necessary for documenting communications within Clinical Trial Management Systems (CTMS), electronic Trial Master Files (eTMF), and site files. We will…

Site Communications & Issue Escalation

Oversight Models for Home Health, Direct-to-Patient Shipments and Local Labs

November 16, 2025November 15, 2025 digi

Oversight Models for Home Health, Direct-to-Patient Shipments and Local Labs Oversight Models for Home Health, Direct-to-Patient Shipments and Local Labs The evolution of clinical trial practices has been significantly impacted by innovations in technology, particularly in the areas of home health, direct-to-patient shipments, and local laboratory utilization. As clinical operations professionals, along with regulatory and…

GCP in Digital/Decentralized Settings

Validating Digital Platforms Under GCP and Computer System Validation

November 16, 2025November 15, 2025 digi

Validating Digital Platforms Under GCP and Computer System Validation Validating Digital Platforms Under GCP and Computer System Validation In recent years, the rapid advancement of digital technologies has transformed the landscape of clinical research. With the advent of mobile applications, electronic data capture (EDC) systems, and decentralized clinical trial approaches, the need for robust validation…

GCP in Digital/Decentralized Settings

Routine vs Urgent Communications: Channels, Templates and Expectations

November 16, 2025December 30, 2025 digi

Routine vs Urgent Communications: Channels, Templates and Expectations Routine vs Urgent Communications: Channels, Templates and Expectations In the realm of clinical trial management, effective communication is paramount. Whether one is engaging in pharmaceutical clinical trials, managing COVID clinical trials, or investigating specific treatments like the VX 880 clinical trial, distinctions between routine and urgent communications…

Site Communications & Issue Escalation

Routine vs Urgent Communications: Channels, Templates and Expectations

November 16, 2025November 15, 2025 digi

Routine vs Urgent Communications: Channels, Templates and Expectations Routine vs Urgent Communications: Channels, Templates and Expectations Introduction to Clinical Trial Management in Communication Effective communication is a cornerstone of successful clinical trial management. In the realm of pharmaceutical clinical trials, especially considering the complexities introduced by evolving situations such as the COVID-19 pandemic, understanding the…

Site Communications & Issue Escalation

Managing Protocol Clarifications and FAQs Across Global Site Networks

November 16, 2025November 15, 2025 digi

Managing Protocol Clarifications and FAQs Across Global Site Networks Managing Protocol Clarifications and FAQs Across Global Site Networks The complexity of pharmaceutical clinical trials requires precise communication across various stakeholders, including clinical sites, sponsors, and regulatory authorities. This complexity can be particularly pronounced when dealing with protocol clarifications and Frequently Asked Questions (FAQs). This article…

Site Communications & Issue Escalation

Regulatory Expectations for eConsent, Telemedicine and Remote Visits

November 16, 2025November 15, 2025 digi

Regulatory Expectations for eConsent, Telemedicine and Remote Visits Regulatory Expectations for eConsent, Telemedicine and Remote Visits In recent years, the landscape of clinical trials has undergone a significant transformation, particularly with the advent of digital technologies. This change is characterized by an increasingly common integration of eConsent, telemedicine, and remote visits into clinical trial methodologies….

GCP in Digital/Decentralized Settings

Data Integrity and Privacy Controls in App- and Device-Driven Studies

November 16, 2025November 15, 2025 digi

Data Integrity and Privacy Controls in App- and Device-Driven Studies Data Integrity and Privacy Controls in App- and Device-Driven Studies In recent years, clinical trial methodologies have evolved significantly with the advent of technology. App- and device-driven studies, often referred to as digital or decentralized clinical trials, are becoming more prevalent due to their potential…

GCP in Digital/Decentralized Settings